Decongestive therapy and renal function in acute heart failure: time for a new approach?
From the University of Minnesota, Minneapolis (S.R.G., B.A.B.); Division of Cardiology (S.R.G, B.A.B), Hennepin County Medical Center, Minneapolis, MN; Minnesota Heart Failure Consortium, Minneapolis Medical Research Foundation (S.R.G.); and Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN (J.B.). sgoldsmith.md@gmail.com.
Steven R
SR
Goldsmith
From the University of Minnesota, Minneapolis (S.R.G., B.A.B.); Division of Cardiology (S.R.G, B.A.B), Hennepin County Medical Center, Minneapolis, MN; Minnesota Heart Failure Consortium, Minneapolis Medical Research Foundation (S.R.G.); and Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN (J.B.).
Bradley A
BA
Bart
From the University of Minnesota, Minneapolis (S.R.G., B.A.B.); Division of Cardiology (S.R.G, B.A.B), Hennepin County Medical Center, Minneapolis, MN; Minnesota Heart Failure Consortium, Minneapolis Medical Research Foundation (S.R.G.); and Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN (J.B.).
John
J
Burnett
D000208:Acute Disease; D001552:Benzazepines / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D006333:Heart Failure / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D020097:Natriuretic Peptide, Brain / Q000627:therapeutic use; D000077602:Tolvaptan; D014462:Ultrafiltration
D001552:Benzazepines; D020097:Natriuretic Peptide, Brain; D000077602:Tolvaptan; D004298:Dopamine
heart failure